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Resting  T  cells  can  be  activated  to  proliferate by antigens and  mitogenic 
lectins, but their proliferation depends on a  hormone-like lymphokine, T  cell 
growth factor or interleukin 2 (IL-2)  ~ (1-2). Activation of T  cells by a mitogenic 
stimulus induces both secretion of minute quantities of IL-2 and the appearance 
of a high-affinity receptor for IL-2 on the T  cell surface (3-4). This receptor has 
been identified as a 50,000 dalton protein, not detectable on resting T  cells, that 
is recognized by the monoclonal antibody anti-Tac (4-6).  Several lines of evi- 
dence suggest that resting natural killer (NK) cells can respond directly to IL-2, 
with enhanced cytotoxic activity and eventually proliferation, with no additional 
requirement for other activation stimuli. IL-2°containing preparations, free of 
antiviral activity, enhance NK cell activity in mouse spleen cells (7-9)  and  in 
human peripheral  blood  lymphocyte (8,  10,  11)  (PBL)  cultures in  a  manner 
similar to that of interferon (IFN). IL-2 induces production of IFN-7 in leukocyte 
cultures (11-14) by a mechanism that, in the mouse, depends upon cooperation 
between macrophages and cells with NK characteristics (14).  It has been sug- 
gested that the enhancement of NK activity induced by IL-2 is mediated by the 
IFN-~' produced in the culture, since anti-IFN-3, antisera abolish the effect (8). 
IL-2 has also been  shown to induce proliferation and production of IFN-3~ by 
low density human PBL purified on discontinuous Perco|l gradients (11,  15). 
However, those studies, based on the use of gradient separation and of monoclo- 
nal antibodies of only relative specificity for NK cells, do not allow a distinction 
between the possibilities that proliferation and IFN-~' production are confined 
to NK cells, or are in part or entirely a  property of in vivo activated T  cells, 
copurifying with NK cells in low density Percoll fractions. In addition to enhanc- 
ing NK activity in short-term cultures, IL-2 can induce, in in vitro cultures of 
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three or more days, cells cytotoxic for  NK-insensitive  tumor target  cells (16). 
These effector cells, termed lymphokine-activated killer (LAK) cells, bear mark- 
ers  of cytotoxic T  cells but derive  from  precursor  cells that  lack  markers  of 
either T  or NK cells and copurify with NK cells on a Percoll gradient (17). 
Recently  (18,  19),  the  gene  for  human  IL-2  has  been  cloned  in  several 
laboratories  and  this  has  allowed  purification  of homogeneous  recombinant 
IL-2  (rIL-2)  from  transfected  Escherichia  coli.  With  this  material,  it  becomes 
possible to assay the effect of IL-2 on human NK cells and exclude any effect of 
contaminants such as lectins, phorbol esters, IFN, or other lymphokines. 
In the present paper, we show that rIL-2 induces a rapid and potent enhance- 
ment of the spontaneous cytotoxicity of human lymphocytes. The IL-2-induced 
cytotoxic effector cells have surface markers of NK cells and are generated from 
the same PBL subset mediating spontaneous NK activity. Like IFN, IL-2 induces 
increased cytotoxicity against a large panel of NK-sensitive or relatively resistant 
target cells, rIL-2 induces IFN-y production in lymphocyte cultures and, in short- 
term cultures,  NK cells appear to be the major producer cells, whereas T  cells 
are unable to produce IFN-'r in response to rIL-2. The kinetics of enhancement 
of cytotoxicity and production of IFN-7 and the inability of monoclonal antibod- 
ies to IFN-3, to suppress the IL-2-dependent  NK enhancement suggest that the 
effect of rIL-2 on NK cells is independent  of IFN-3,. The enhancement of NK 
cell activity by rIL-2 precedes any proliferative response of the lymphocytes. By 
contrast, proliferation is observed in longer cultures in cells with both NK or T 
cell markers. 
Materials and Methods 
Lyraphokines.  IL-2 was produced at high levels by E. coli transfected with an expression 
plasmid containing the IL-2-coding  region cloned from human lymphocytes  (18). Har- 
vested E. coli were resuspended (40 g packed cells in 100 mi final volume) in 50 mM Tris- 
HCI (pH 7.5), 2% (vol/vol) Triton X-100 and sonicated at 20 kHz for 10 min. Vesicles 
containing  IL-2 were collected by centrifugation,  washed  twice with  phosphate buffer 
(0.1 M, pH 4.5), and dissolved in the same buffer supplemented with 1% (wt/vol) sodium 
dodecyl sulfate (SDS) and  5%  (vol/vol)  2-mercaptoethanol.  The  protein  solution  was 
purified by high pressure liquid chomatography first on a gel permeation column and 
then by reverse phase chromatography. Protein concentration was determined by a dye- 
binding assay using bovine plasma gamma globulins as a standard (Bio-Rad Laboratories, 
Richmond, CA). The purity of the IL-2 preparations was >99% and the specific activity 
was 3-10 x  106 U/mg (1 U being the amount of IL-2 giving 50% of the maximal [~H]- 
thymidine ([SH]TdR) incorporation in the cytotoxic T  lymphocyte line (CTLL) assay, as 
described below). Contamination with endotoxins was excluded using the limulus ame- 
bocyte lysate assay (E-Toxate; Sigma Chemical Co., St. Louis, MO). Affinity-purified  IFN- 
3, (106 U/mg) and  purified  IFN-a (Ultra-pure  IFNa,  l0 s U/mg) were obtained from 
Interferon Sciences, New Brunswick, NJ. 
Electrophoresis.  SDS-polyacrylamide gel electrophoresis was performed on  10% poly- 
acrylamide  vertical slab gels according to a modification  of the Laemmli procedure (20). 
After electrophoresis,  gels were stained by the silver staining  method (Bio-Rad Labora- 
tories).  Molecular  weight  standards  were  obtained  from  Pharmacia  Fine  Chemicals, 
Uppsala, Sweden. 
IL-2  Biologic  Assay.  IL-2  growth-promoting  activity  was  determined  by the  IL-2 
concentration-dependent stimulation  of proliferation of CTLL-2, a cloned murine cyto- 
toxic T  lymphocyte line (2, 21). CTLL (5 X 104 cells/mi) proliferation was monitored by 
[3H]TdR incorporation (5 #Ci/ml,  2 Ci/mmol specific activity;  New England  Nuclear, TRINCHIEP, I  ET AL.  1149 
Boston, MA) during the last 6 h of a 24-h culture in the presence of serial dilutions of the 
IL-2 preparation. 
Monoclonal Antibodies and Antisera.  Two monoclonal antibodies, specific for the FcR 
for aggregated IgG on NK cells and neutrophils, were used in this study: B73.1 (IgG1), 
produced in our laboratory (22, 23) and VEP13 (IgM) (24), kindly provided by Dr. H. 
Rumpold (Institute of Experimental  Pathology, Vienna,  Austria).  The two antibodies 
react with two different epitopes of the same surface molecule. The reactivity of antibody 
B73.1 on neutrophiis is absent or reduced as compared with that of VEP13 (25, 26), and 
only antibody VEP13 is cytotoxic with complement (C). Among peripheral blood mono- 
nuclear cells, virtually all NK cells, but not T  cells, B cells, or monocytes are detected by 
the two antibodies (22-26).  Antibody HNK-1  (IgM) (27), which reacts with a  variable 
proportion of NK and T  cells in the peripheral blood (22, 28), was produced from cell 
cultures obtained from American Type Culture Collection, Rockville, MD. Antibody Leu- 
4  (IgG1), reacting with the  20,000  tool wt surface molecule present on all peripheral 
blood T  cells,  was  kindly provided by Dr.  N.  Warner (Becton Dickinson Monoclonal 
Center, Sunnyvale, CA).  Monoclonal antibody anti-Tac (IgG2a) (5) was kindly donated 
by Dr. T. Waldman (NIH, Bethesda, MD).  Antibody OKM1  (IgG2a), reacting with the 
heavy chain of a  complex of two polypeptide chains of 95,000  and  177,000 daltons, 
corresponding to the receptor for C3bi  (29) present on monocytes, granulocytes, and 
most NK cells, was kindly provided by Dr. G. Goldstein (Ortho Pharmaceutical, Raritan, 
NJ).  Antibodies  B67.1  (IgG2a),  specific  for  the  45,000  mol  wt  receptor  for  sheep 
erythrocytes (ER) (23); B36.1  (IgG2b), of specificity identical to that of anti-Leu-1 (22) 
and detecting a  69,000  mol wt molecule present on all peripheral blood T  cells;  and 
B33.1 (IgG2a), detecting a nonpolymorphic determinant of the HLA-DR molecule (23), 
were produced in our laboratory. An IgG2a monoclonal antibody (X-400) with neutral- 
izing activity against IFN-7 was obtained from Meloy Laboratories, Inc., Springfield, VA 
as a stock solution neutralizing 20,000 U of the Gg23-901-530 NIH IFN-3, standard per 
milliliter. Monoclonal antibodies B 133.1 and B133.3 (both I gG1) were produced in our 
laboratory and react specifically with human IFN-~/and not with either IFN-a or -~/. The 
tissue  culture  supernatant  fluids from  B133.1  and  B133.3  used  in  the  present  study 
neutralized 3,600 and 32,400 U of the NIH IFN-3, standard per milliliter, respectively. 
A  sheep antiserum  against  human  IFN-a  (105  neutralizing  U/ml)  was  obtained from 
Interferon Sciences. A  neutralizing rabbit antiserum anti-human IL-2 was obtained by 
immunization with  homogeneous rIL-2: the antiserum  did  not show any neutralizing 
activity against  IFN. The preparation used inhibited the growth-promoting activity of 
1.25 ~g of rIL-2 per milliliter. 
PBL Preparations.  Venous peripheral blood was obtained from healthy donors and 
was anticoagulated with heparin. Mononuclear cells were prepared by Ficoll-Hypaque (F/ 
H) gradient centrifugation and,  unless otherwise indicated, were partially depleted of 
monocytes by  adherence  on  plastic  petri  dishes  (No.  3024,  Falcon  Plastics,  Becton 
Dickinson & Co., Cockeysville, MD) for 1 h at 37°C. These monocyte-depleted prepara- 
tions are referred to in the text as PBL. Lymphocyte cultures were maintained at 37°C 
X  10  cells/ml) in  RPMI  1640 medium (Flow  in a  5% CO~ humidified atmosphere (5  6 
Laboratories, Rockville, MD) supplemented with  10%  fetal bovine serum (FBS) (Flow 
Laboratories). 
Cell Lines.  The human erythro-myeloid leukemia cell line K562, the promyelocytic 
lines HL-60 and ML3, the macrophage line U937, the B cell lines Raji and Daudi, the T 
cell lines Molt 4 and Jurkat, the fetal skin fibroblast strains HF-28 and Detroit 532, the 
rhabdomyosarcoma-derived line RDMC, and the melanoma-derived line SK-Mel/23, were 
maintained in culture in RPMI  1640 medium supplemented with 10% FBS. 
Spontaneous Cell-mediated Cytotoxicity (CMC) Assays.  The spontaneous CMC assay was 
performed in round-bottom microtiter plates as described, using 5~Cr-labeled target cells 
5~  (104 cells/well) in  a  3-h assay (30).  Adherent target cells  were labeled with  Cr as a 
monolayer and trypsinized immediately before use as a target cell suspension. All CMC 
assays were always performed using at least four different effector cell concentrations. 
Standard deviation of triplicate wells was usually < 1%. Results were quantitated at various 1150  NATURAL  KILLER CELLS  AND  INTERLEUKIN 2 
effector-to-target cell ratios by calculating the number of lytic units (LU) per 107 cells at 
45 % specific lysis with the use of the linear regression to a modified von Krogh's equation 
(31-33). One LU is the number of effector cells necessary to lyse 45% of the target cells 
during the assay period. 
Complement-dependent Lysis (CdL).  Rabbit  complement  (C)  from  baby  rabbits  was 
obtained  from  Cedarlane  Laboratories  Ltd.,  Hornby,  Ontario,  Canada  and  screened 
among several lots for high iytic titer and low toxicity. PBL were incubated (30 min at 
4 ° C) with an optimal predetermined concentration of the monoclonal antibodies. Rabbit 
C was then added (10  -~ dilution) and the incubation  continued for  1 h  at 37°C.  Dead 
cells were scored immediately by erythrosin  B  dye exclusion.  Cells were then  washed 
twice, resuspended in culture medium at the original volume, and used for cytotoxic tests 
or IFN production.  We did not correct cell concentration for the number of remaining 
live cells to allow a  quantitative  evaluation of the  decrease in  cytotoxicity due  to the 
eliminated subpopulation.  A  slight decrease in  NK cell cytotoxicity was sometimes ob- 
served in C-treated control populations in comparison with the untreated ones. 
Separation of Lymphocyte Subpopulations.  Cells  were  incubated  with  the  monoclonal 
antibodies (1 ttg/ml, 30 min at 4°C), washed three times in phosphate-buffered saline, pH 
7.2 (PBS), and incubated for 30 min at 4°C as pellets with CrCls-treated sheep erythrocytes 
(E) (22) coated with a  goat F(ab')~ antibody anti-mouse Ig (E to PBL ratio,  50:1).  The 
goat F(ab')~ anti-mouse Ig (Cappel Laboratories, Cochranville, PA) was preabsorbed on a 
human Ig-Sepharose 4B (Pharmacia Fine Chemicals) column to eliminate antibodies cross- 
reactive with human Ig, and then affinity-purified on a mouse Ig-Sepharose 4B (Pharmacia 
Fine  Chemicals)  column.  The  use  of affinity-purified  antibodies  completely prevents 
background in the absence of an antibody reacting with the cells, and increases efficiency 
of the separation method.  No spontaneous rosette formation was ever observed in the 
control  population  under the  same experimental conditions,  since  CrCIs treatment of 
sheep E and the experimental conditions used do not allow E rosette formation by T cells. 
The proportion of rosette-forming cells was evaluated by scoring at least 200 cells by light 
microscopy. 
Rosetting and  nonrosetting cells  were  then  separated  on  a  one-step  F/H  gradient. 
Contaminating E in the antibody-positive (rosetting) fraction were lysed by treatment with 
hypotonic medium. A portion of cells was tested before F/H separation for the effect of 
antibody and rosetting. The values of cytotoxic activity observed in this control and in 
the total untreated  lymphocyte preparation were similar, although occasionally NK cell 
cytotoxicity decreased slightly in the control unseparated population. 
Thymidine Incorporation and Simultaneous  Detection of Thymidine Incorporation and Surface 
Antigen Expression.  PBL or separated subsets were cultured (106 celis/ml) and [SH]TdR 
(1 mCi/ml, 2 Ci/mmol sp act; New England Nuclear) was added to the culture during the 
last 2  h  (1  #Ci/well).  Cells were collected on glass fiber filters using an automatic cell 
harvester (Skatron  Inc.,  Sterling,  VA) and  the  incorporated  [SH]TdR  was assayed by 
liquid scintillation.  For the simultaneous detection  of cells incorporating [3H]TdR and 
cells expressing surface antigens, after the [3H]TdR pulse, the cells were washed, sensitized 
with a  monoclonal antibody and allowed  to  react  with  anti-mouse Ig-coated sheep  E, 
according to the technique of indirect rosetting described above. Cytocentrifuge smears 
were prepared, fixed with absolute methanol for 30 min, covered with NTB-2 emulsion 
(Eastman Kodak Company, Rochester,  NY) and developed after a  2-d exposure.  Cells 
reacting with the antibody were identifiable on the slide by formation of rosettes with 
sheep E. The proportion of cells having incorporated [~H]TdR was scored within antigen- 
positive and -negative cells. 
Indirect Immunofluorescence  Assay.  Cells were incubated with the monoclonal antibody 
(30 min at 4 °C), washed three times, and incubated with a  1:80 dilution of a fluorescein 
isothiocyanate (FITC)-conjugated goat F(ab')2 anti-mouse Ig (Cappel Laboratories) ab- 
sorbed on a column of human Ig-Sepharose 4B. All washes were done in PBS containing 
0.1% gelatin and 0.1% NAN3. An Ortho Cytofluorograf System H50 connected to a Data 
General  MP/200  miroprocessor (Ortho  Diagnostic Systems, Inc.,  Westwood,  MA) was 
used  for  analysis  of the  fluorescent  cells.  Cells  were  considered  positive when  their TRINCHIERI  ET  AL.  1151 
fluorescence intensity exceeded the level at which 99% of the cells in the negative control, 
treated with the second immunofluorescent reagent only, had lower fluorescence intensity 
(34). 
Interferon Assay.  Antiviral activity was tested in supernatant fluids by inhibition of the 
cytopathic effect of vesicular stomatitis virus (VSV) on human fibroblast strain  Detroit 
532,  derived from a  subject  with  trisomy 21.  The  IFN  concentration inducing  50% 
protection of the cytopathic effect on Detroit 532 cells corresponded to ~ 1 U of the NIH 
IFN-~, standard Gg23-901-530 and to 0.1  U of the NIH IFN-a standard Gg23-901-527. 
Results 
Characterization and Growth-promoting Activity of rlL-2.  The rlL-2 preparation 
appears  as  a  homogeneous  silver-stained  band  of  15,000  mol  wt  on  SDS  gel 
under reducing conditions (Fig. 1, left), and monoclonal antibodies to IL-2 bound 
to the band as demonstrated by immunoblotting (not shown). The faint band of 
30,000 apparent mol wt is probably a  dimer of the IL-2 molecule, because it is 
not resolved when the sample is boiled extensively in the presence of SDS, and 
because  it  is  stained  with  monoclonal  anti-IL-2  antibodies  (not shown).  These 
data are consistent with previous reports (35) that functionally active dimers of 
natural  IL-2  can  be demonstrated  on  SDS gels.  Growth-promoting activity (as 
tested on CTLL cells) was concentrated in proteins eluting at the 15,000 mol wt 
position  (not  shown).  The  dose  of rIL-2  that  induced  50%  of the  maximum 
[SH]TdR incorporation by CTLL cells was ~3 ng/ml in this preparation of rIL- 
2 (Fig. 2). Considering some variability in different preparations and the lack of 
standardized  methods  for determination  of IL-2 activity and  protein  content, 
FIGURE  1.  Electrophoresis ot purified rIL-2. 1 #g rIL-2 was run on an SDS-10% polyacryl- 
amide slab gel under reducing conditions (left). Molecular weight markers were run on an 
adjacent lane in the same slab gel (r/gh  0. Protein bands were detected using silver staining. 1152  NATURAL  KILLER CELLS AND  INTERLEUKIN  2 
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FIGURE 2.  Growth-inducing and cytotoxicity-enhancing ability of rlL-2,  rlL-2  at various 
concentrations was tested for its ability to induce [SH]TdR uptake in murine CTLL cells (48 
h culture, 5 x  104 cells/ml) (I) and to enhance the spontaneous cytotoxicity of human PBL 
(pretreated for 18 h at 37°C at 5 x  106 cells/ml) against RDMC target cells in a 3-h 5]Cr- 
release assay. The increase of cytotoxicity is expressed as the ratio between LU of the PBL 
cultured in the presence or absence of rlL-2; the open circles and the bars represent mean + 
standard error of the results obtained with four different donors. 
the specific activity of rIL-2  is comparable  to that reported for natural IL-2. 
Enhancement of Spontaneous Cytotoxic Activity of Human PBL.  A  dose-depend- 
ent enhancement  of spontaneous cytotoxicity was observed  in PBL cultured for 
18 h  in the presence  of rIL-2, at concentrations >20  ng/ml  (Fig.  2).  The effect 
was demonstrable,  at the same concentrations of rIL-2, with target cells that are 
either very sensitive (Fig. 3 a) or relatively resistant (Fig. 3 b) to NK cell-mediated 
lysis. Optimal concentrations of IFN-a (500 U/ml) and rIL-2 (0.2 •g/ml)  induced 
a similar pattern of enhancement of PBL-mediated cytotoxicity against 10 human 
cell  lines of different  histological  origin,  although cytotoxicity was  consistently 
enhanced to higher levels with rIL-2 (Table I). Both IFN-a and rIL-2 enhanced 
the  cytotoxicity  of  PBL  against  target  cell  lines  susceptible  to  spontaneous 
cytotoxicity and also induced high levels of cytotoxicity against relatively resistant 
target cells  that were  not significantly  iysed by PBL  from  most donors in a  3-h 
cytotoxic assay (Table  I).  The enhancement  of PBL  cytotoxicity observed  with 
effective  doses of rIL-2  was significant  in assays performed  after a  2-5-h prein- 
cubation  in  the  presence  of rIL-2  and  reached  a  maximum  after  a  12-18-h 
preincubation (Fig. 4, top). 
Phenotypic Characterization  of the IL-2-induced  Cytotoxic PBL.  To identify the 
surface  phenotype  of the  cytotoxic  cells  induced  by  rIL-2,  PBL  were  treated 
with various antilymphocyte  subset  monoclonal antibodies and C  either  before 
or after culturing in the presence of rIL-2 and the level of cytotoxicity mediated 
by the PBL was measured. Fig. 5 shows the results of a representative experiment. 
The  anti-HLA-DR  antibody  B33.1  and  the  anti-pan  T  cells  B36.1  did  not TRINCHIERI  ET  AL.  1153 
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FIGURE 3.  rlL-2-induced  enhancement  of spontaneous  cytotoxicity by  human  PBL.  PBL 
were incubated (18 h at 37°C, 5 x 106 cells/ml) in culture medium, in the presence or absence 
of different concentrations of rlL-2, washed, and tested as effector cells against 104 K562 (a) 
or RDMC (b) target cells, in a 3-h S~Cr-release cytotoxicity  assay. Pretreatment of PBL was: 
none (O); rlL-2 at (O) 5 ng/ml, (A) 15 ng/ml, (A) 44 ng/ml, (11) 133 ng/ml, (I-1) 400 ng/ml. 
significantly affect cytotoxicity. Both spontaneous cytotoxicity and cytotoxicity 
enhanced  by rIL-2,  either  before or after  CdL,  were partially  inhibited  and 
almost completely abrogated after treatment  with  the anti-ER antibody B67.1 
and with the anti-FcR antibody VEP 13, respectively. Antibody HNK-1 and the 
anti-C3biR  antibody  OKM 1 inhibited  to some extent the  cytotoxicity of PBL 
from different donors: the extent by which the two antibodies inhibited sponta- 
neous  cytotoxicity approximated  that  by which  they  inhibited  rIL-2-induced 
cytotoxicity of PBL from the same donor (experiments not shown). To confirm 
the results obtained by depletion of cell subsets with antibody and C, PBL were 
positively and negatively selected after sensitization  with the anti-FcR antibody 
B73.1 and the anti-pan T  cell antibody B36.1, cultured for 18 h in the presence 
or absence  of rIL-2,  and  assayed for  cytotoxicity. As  shown  in  Fig.  6,  which 
depicts the results of one representative experiment out of six performed, both 
spontaneous cytotoxicity of PBL and cytotoxicity induced by culture with three 
different concentrations of rILo2 were almost completely restricted to B73.1 + or 
B36.1- cells. Thus, cytotoxic PBL induced by rI L-2 in a short-term (18 h) culture 
have a  surface phenotype corresponding to that  of spontaneous NK cells; fur- 
thermore, the cytotoxic cells induced derive from mature cells. 
Effect of rlL-2 on the Expression of Lymphocyte Surface Markers in Short-term (18 
h) Cultures of PBL.  A panel of antilymphocyte monoclonal antibodies was tested 
by indirect  immunofluorescence  on  PBL cultured  in  the  presence  of rIL-2  at 
doses optimal  for enhancing  cytotoxicity. The  proportion  of positive cells and 
the antigen  density (fluorescence intensity) were determined  by flow cytofluo- 1 154  NATURAL  KILLER CELLS AND  INTERLEUKIN  2 
TABLE  I 
Effect of Treatment with IFN-a or rlL-2 on the Spontaneous  Cytotoxicity of PBL Against 
Various Human Cell Lines 
Target cells  Origin 
Treatment of PBL* 
None  IFN-a  rlL-2 
K562  Chronic myeloid leukemia  32.7*  73.1  120.2 
Daudi  Burkitt lymphoma  13.3  36.4  77.8 
Raji  Burkitt lymphoma  <2  3.6  11.0 
Molt 4  T lymphoma  4.4  8.2  20.7 
Jurkat  T lymphoma  13.9  74.8  169.5 
HL-60  Acute myeloid leukemia  <2  2.4  9.3 
U937  Acute monocytic leukemia  78.1  147.8  262.1 
HF-28  Skin fibroblasts  <2  3.1  6.5 
RDMC  Rhabdomyosarcoma  <2  23.2  51.4 
SK-Me123  Melanoma  <2  4.1  12.1 
* PBL were incubated for 18 h at 37 °C in culture medium or in medium containing 500 U/ml IFN- 
a or 0.2 ~g/ml rIL-2. 
* Lytic units 45% per l0  T  PBL, in a 3-h SlCr-release  assay. 
rometric analysis, rlL-2 treatment did not affect the expression of HLA-DR, pan 
T  antigens (Leu-4 and B36.1), ER, and markers of the helper and suppressor T 
cell subsets.  Also,  neither  the  intensity of fluorescence nor  the  proportion  of 
reactive cells changed when monoclonal antibodies reacting with all or a propor- 
tion of NK cells,  including  OKT10,  B73.1,  HNK-1,  and  N90!, were assayed. 
On the other hand,  expression of C3biR,  as detected by antibody OKM1,  was 
consistently increased:  the number of OKM1 ÷ cells was  not changed  (on  PBL 
from five different donors,  17.0  +  6.1%  of the  PBL cultured in  medium and 
16.7 +  6.2% of the PBL cultured for 18 h  in the presence of 400 ng/ml rIL-2 
were OKM 1  +, but the intensity of fluorescence on the positive cells of five out 
of five donors  was  increased.  Using  arbitrary  units  (channels)  of fluorescence 
from 1 to 200, the fluorescence intensity of OKM 1  + PBL, cultured in medium, 
was 85.7 +  14.2 and that of PBL cultured in rIL-2, 95.8 ___ 10.3 
Production  of Immune  IFN  by  PBL  Cultured  in  the  Presence  of rlL-2.  The 
supernatant fluid from PBL cultured in the presence ofrIL-2 contained antiviral 
activity. This was induced by rIL-2 in a  dose-dependent  fashion and  could be 
detected in the supernatant  fluid of the PBL cultured in the presence of rIL-2 
at  12  h  of incubation or longer (Fig.  4, bottom).  The IFN titer on  Detroit 532 
cells in experiments with PBL from a  total of 23 donors (18 h  incubation with 
0.4  ~g/ml  rIL-2) was  34  ---  38  (~ +  SD).  The ability of lymphocyte subsets  to 
produce  IFN  in  response  to  rIL-2  was  analyzed:  B73.1 ÷  and  B36.1-  cells 
consistently produced high titers of IFN, whereas B36.1 ÷ T  cells produced none 
(Fig.  7).  B73.1-  PBL from some donors were unable to produce IFN, whereas 
those from other donors produced some, although  less than  unseparated  PBL. 
The antiviral  activity produced  by B73.1 ÷ and  B36.1- cells was  characterized 
using antMFN antibodies, and was found to be almost exclusively IFN-3, (Table 
I1). 
Effect  of Anti-IFN-%  Anti-IL-2,  and Anti-Tac  Antibodies  on  rlL-2-induced  PBL TR1NCHIERI  ET  AL,  1155 
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FIGURE  4.  Kinetics of enhancement of spontaneous cytotoxicity and IFN production induced 
by rlL-2.  PBL were cultured (37°C,  5  x  l0 s cells/ml) for different times in the presence or 
absence of rlL-2. Supernatant fluids were collected for IFN assay and PBL were washed and 
tested as effector cells against RDMC target cells in a 3-h 5~Cr-release cytotoxicity  assay (top). 
The antiviral titer was assayed  on Detroit 532 cells (bottom). rlL-2 concentrations in the culture 
were: (A) 44 ng/ml, (I) 133 ng/ml, (El) 400 ng/ml. 
Cytotoxicity.  The enhancement  of PBL cytotoxicity and the  IFN-3, production 
induced by rIL-2 were completely abrogated by rabbit anti-IL-2 antibodies (Fig. 
8 and Table III). Three different anti-IFN-y monoclonal antibodies, at concen- 
trations able to completely neutralize the antiviral titer in the culture supernatant 
fluids and to prevent the enhancement  of NK activity by doses of IFN-3, much 
higher than  those produced in the rIL-2-containing  PBL culture,  were unable 
to prevent the enhancement  of PBL cytotoxicity induced by rIL-2, although  a 
modest decrease of the cytotoxic efficiency of the rIL-2-treated  PBL was occa- 
sionally observed (Fig.  8 and Table  III).  The  IL-2 receptor antibody anti-Tac 
(ascitic fluid dilutions,  1:200  and  1:600)  was also unable  to  inhibit  the  rIL-2- 
mediated enhancement of PBL cytotoxicity (Table III). Spontaneous or IFN-3,- 
induced cytotoxicity was not significantly affected by either antibody concentra- 
tions used in these experiments (not shown). 
Induction of PBL Proliferation by rlL-2.  B73.1-positive and -negative PBL from 
three different donors were cultured for 6  d  in the presence or absence of 20 
ng/ml rIL-2, and the incorporation of [3H]TdR in the last 6 h of the culture was 
evaluated  (Table  IV).  The  purity  of  the  separated  cells  was  confirmed  by 
evaluating surface markers and by testing the NK cytotoxic activity of the two 
fractions  (not  shown),  rIL-2  induced  proliferation  in  both  B73.1-positive  and 1156  NATURAL  KILLER  CELLS  AND  INTERLEUK1N  2 
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FIGURE 5.  Surface markers on Ik-2-induced effector cells, evaluated by treatment of a PBL 
preparation with monoclonal antibodies and C, before or after culture in the presence of rIL- 
2.  The  figure  depicts  the  cytotoxicity (RDMC  target  cells,  3-h  5~Cr-release  assay)  of the 
following effector cell preparations: PBL first treated with antibodies and C and then cultured 
(18 h, 37°C) in the absence (a) or presence (b) of 133 ng/ml rIL-2; PBL cultured (18 h, 37°C) 
in the absence (c) or presence (d) of 133 ng]ml rIL-2 and then treated with antibodies and C. 
Antibodies used were: (O) none (C only), (O) B33.1 and C, (A) B36.1 and C, (A) VEPI3 and 
C, (F1) B67.1 and C. 
-negative PBL in two donors, but only in the B73.1 + cells from a  third  donor. 
The rlL-2-induced proliferation was abolished if rabbit anti-IL-2 antibodies were 
present  in  the  culture  (Table  IV).  To  determine  whether  this  rlL-2-induced 
proliferation could play a role in the enhancement of cytotoxicity in short-term 
cultures, PBL from three other donors were cultured for 1 or 4 d in the presence 
and absence of rlL-2,  and  [3H]TdR was added to the cultures  during  the  last 
hour of incubation  (Table V).  The  cytotoxic ability of the cells was measured 
against RDMC and K562 target cells; [3H]TdR incorporation and expression of 
the NK antigen  recognized by antibody B73.1, or of the T  cell antigen, recog- 
nized by antibody Leu-4,  were simultaneously detected using autoradiography 
and  indirect  rosetting,  rlL-2  induced  a  strong  enhancement  of cytotoxicity, 
detectable on  both  target  cells at  days  1 and  4.  An  increase  in  the  levels of 
cytotoxicity, especially in  control  PBL  cultured  in  the  absence  of rlL-2,  was 
apparent on day 4, although caution should be used in comparing values obtained 
in cytotoxicity experiments performed on different days. On day  1, no Leu-4  + 
or B73.1 ÷ cells incorporating [3H]TdR were detected, even though >1,000 cells 
per experimental condition were scored (Table V). On day 4, a small proportion 
of the PBL cultured with medium only, and a  much larger proportion of those 
cultured in the presence ofrlL-2, incorporated [3H]TdR. [SH]TdR-incorporating 
cells were detected in both the Leu-4 ÷ and the B73.1 ÷ subsets in all three donors, 
with donor to donor variation in the relative frequency. TRINCHIERI  ET  AL.  1157 
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FIGURE 7.  IFN production by different PBL subsets upon exposure to rIL-2. B37.1  (+) and 
(-) and B36.1  (+) and (-) cells were obtained by separation on an F]H gradient of cells after 
sensitization with the monoclonal antibodies and formation of indirect rosettes. PBL or PBL 
subsets were incubated 18 h at 37°C (5 x  106 ceils/ml) in medium or in the presence of the 
indicated concentrations of rIL-2.  IFN was measured in the culture supernatant fluid. Bars 
indicate the means of experiments with four different PBL donors; error bars are standard 
deviation. 
TABLE  II 
Characterization of the Antiviral Activity Produced by Human Lymphocytes upon Induction 
with rlL-2 
IFN assay* in the presence of: 
IFN preparation  Anti-IFN-a + anti- 
No Ab  Anti-IFN-a  Anti-IFN-3,  IFN-3' 
IFN-a  2187*  <1  2187  ND  g 
IFN-'~  81  81  <1  ND 
Donor 1. B73.1 ÷ cells +  81  81  1  <1 
rIL-2  I 
Donor 2. B73.1 + cells +  243  243  1  <1 
rIL-2 
Donor 2. B36.1- cells +  27  9  1  <1 
rIL-2 
* Samples were mixed  1:1  with medium, anti-IFN-a sheep antiserum (1:10  dilution), anti-IFN-~, 
monoclonal antibody X-1 O0 (1:10 dilution), or with a  mixture of the antibodies, and assayed by 
serial dilutions on Detroit 532 cells for antiviral activity. 
~: Reciprocal of the highest dilution protecting at least 50% of the fibroblasts monolayer from the 
cytopathic effect of VSV. 
J Not done. 
I Cell-free supernatants from 18-h rIL-2-containing (133 ng/ml) cultures of the indicated cell types. TRINCHIERI  ET  AL,  1159 
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FIGURE 8.  Effect  of  anti-lL-2  and  anti-lFN-~'  antibodies  on  the  enhancement  of  PBL- 
mediated cytotoxicity induced by rIL-2 or IFN-7. PBL were cultured (18 h at 37°C, 5 x  106 
cells/ml) in the presence or absence of rIL-2 (133 ng/ml) or IFN-3' (1,000 U/ml), washed, and 
tested as effector cells against RDMC target cells in a 3-h 5~Cr-release  cytotoxicity assay,  in the 
presence or absence of the anti-IFN-~ monodonal antibody B133.3 (culture supernatant fluid, 
1:10) or rabbit anti-IL-2 serum. PBL cultured in medium alone were tested for cytotoxicity in 
the presence of: (0) medium alone, (JD antibody B133.3, (&) anti-IL-2 antibody. PBL cultured 
in the presence of rIL-2 were tested for cytotoxicity in the presence of: (O) medium alone (r-l) 
antibody B 133.3, (A) anti-IL-2 antibodies. PBL cultured in the presence of IFN-~ were tested 
for cytotoxicity in the presence of.. (O) medium alone, (41,) antibody B133.3 
Discussion 
The lineage of human NK cells is still open to question, insofar as these cells 
share phenotypic markers with both myeloid cells and lymphocytes, and reliable 
progenitor  cell assays have not yet been established.  Clones with characteristics 
of NK cells have  been described  that are dependent  for their  growth on IL-2 
(36-40), although other factors or stimuli might be required for optimal growth 
(40,  41).  Resting  lymphocytes  do  not  express  a  significant  number  of  IL-2 
receptors (200 per cell) (4), and reactivity with anti-Tac cannot be demonstrated 
with either peripheral  blood T  cells or  NK cells (5).  Growing NK cells, on the 
contrary, express the high-affinity receptor for IL-2 recognized by the monoclo- 
hal antibody anti-Tac. ~ To respond to  IL-2, T  cells require a stimulus, antigen 
or  mitogen,  able  to  induce  the  expression  of  the  receptor  for  IL-2  (2,  42). 
Instead, a proportion of NK cells have been shown to initiate clonal proliferation 
in response to IL-2, and the T  cell mitogen phytohemagglutinin does not increase 
the  proportion  of proliferating  NK  cells  (38).  Other  studies  (43)  have  shown 
that, among human peripheral  blood cells reacting with antibody HNK-1,  only 
2 London, L., B. Perussia, and G. Trinchieri. Induction of proliferation of resting human NK cells 
in vitro: expression of surface activation antigens.  Manuscript in preparation. 1160  NATURAL KILLER  CELLS  AND  INTERLEUKIN  2 
TABLE  IlI 
Effect of Antibodies to 1FN-% IL-2, or IL-2 Receptor on the Enhancement of PBL Cytotoxieity 
by rlL-2 
Exp.  No. of do-  Inducers*  Antibody  ~  Cytotoxicity  0  IFN-7  ! 
nors 
A  7  None  B133.1  0.98 ± 0.25  q  <1"* 
None  B133.3  0.91 ± 0.23  <1 
rlL-2  None  3.23 zl: 1.89  249 ± 337 
rIL-2  B133.1  2.87 +  1.14  6 ±  13 
rIL-2  B133.3  2.53 ± 0.95  <1 
IFN-'r  None  1.78 ± 0.44  ND  ~* 
IFN-'t  B133.1  0.76 ± 0.33  ND 
IFN-~  B133.3  0.89 ± 0.25  ND 
B  3  None  X-100  1.08 ± 0.29  <1 
rlL-2  None  3.80 +  1.01  96 ± 32 
rlL-2  X-100  4.83 ± 3.02  <1 
C  3  None  Anti-Tac, 1:200  1.04 ± 0.08  ND 
None  Anti-Tac, 1:100  1.07 + 0.04  ND 
rlL-2  None  3.47 ±  1,17  ND 
rlL-2  Anti-Tac, 1:200  3.12 ± 0.39  ND 
rIL-2  Anti-Tac, 1:600  2.88 + 0.64  ND 
D  3  None  Anti IL-2  0.96 + 0.26  <1 
rlL-2  None  4.41 ± 2.33  27 
rIL-2  Anti IL-2  1.02 ± 0.21  <1 
S0 
* PBL were cultured for 18 h (37°C, 5 ×  106 cells/ml) in medium with or without rlL-2 (133 ng/ 
ml) or IFN-~, (500 U/ml). 
Antibodies were added to the PBL cultures at the following concentrations: B 133.1 and B133.3, 
20% supernatant fluid; X-100, 1,000 neutralizing  units/ml;  anti-Tac, ascites fluid, 1:200 or 1:600; 
rabbit anti-IL-2 serum, 1:5. 
e After culture, PBL were washed and tested  as effector  cells in a 3-h 51Cr-release assay against 
RDMC. 
I IFN titer was assayed on Detroit 532 cells in the supernatant fluid of the PBL cultures. 
Numbers represent i  +  SD of the ratio between LU  of PBL  cultured under the  indicated 
experimental conditions  and LU of PBL cultured in medium without inducers or antibodies. 
** Antiviral units (~ + SD). 
Not done. 
those with the mature T  cell phenotype, and not the mature NK cell phenotype, 
are induced to express IL-2 receptors (as detected by anti-Tac) upon treatment 
with  mitogens. Although these  data  have  been interpreted on  the  assumption 
that expression of the IL-2 receptor is induced on putative NK cell precursors, 
they  also  show  that  T  cell  mitogens are  unable to  induce  IL-2  receptors  on 
mature  NK  cells.  Other  soluble factors,  such  as  IFN (44) and cellular stimuli 
(45), reportedly play some role in conferring on NK cells the ability to respond 
to  IL-2.  There  are  other  reports  (7-11,  16,  17,  46,  47)  indicating that  IL-2 
regulates  or  induces  NK  cell  growth,  and  still  others  showing  that  IL-2  can 
induce enhancement  of cytotoxic activity of NK  cells or  of cells with  NK-like 
activity.  This  effect  was  attributed,  in  short-term  cultures  (<1  d),  to  a  rapid 
induction of IFN-~, in  lymphocyte cultures in the  presence of IL-2  (8),  or,  in 
long-term cultures (3-6 d), to an IL-2-induced growth of NK cells (11). Several TRINCHIERI ET  AL. 
TABLE  IV 
rlL-2-induced [SH]TdR Incorporation  in PBL Preparations 
Enriched for or Depleted of NK Cells 
Donor  Lympho-  [3H]TdR incorporation* 
cytes  Medium*  rlL-20  rlL-2 + anti-IL-2  ! 
1  B73.1 +  76  14,839  35 
B73.1-  2,082  29,816  897 
2  B73.1 ÷  86  11,360  62 
B73.1-  9,307  20,041  8,466 
3  B73.1 ÷  332  11,336  54 
B73.1-  319  76  159 
* PBL from three donors were separated  in B73.1 (+ and -) cells by the 
indirect rosetting method and cultured for 6 d (2.5 x  105 cells/ml) in 
flat-bottom microtiter plates in RPMI  1640 medium together with 10% 
human serum. In the last 6  h  of culture, [SH]TdR (1  #Ci/well) was 
added. Cells were collected on glass fiber filters and radioactivity was 
measured by liquid scintillation. 
* Lymphocytes cultured in medium only. 
0 Lymphocytes cultured in the presence of rlL-2 (20 ng/ml). 
! Lymphocytes  cultured in the presence  of rIL-2 and rabbit anti-IL-2 
antibodies. 
TABLE  V 
Cytotoxicity and [3H]TdR Uptake in PBL Cultured in the Presence of rlL-2 
1161 
Donor 
Day 1"  Day 4 
Culture condi- 
tion  Cytotoxicity*  [SH]TdR uptake!  Cytotoxicity  [SH]TdR uptake 
K562  RDMC  Leu-4  +  B73.1  +  K562  RDMC  Leu-4  +  B73.1  + 
1  Medium  61  3  0.0  ~  0.0  39  14  1.2  0.0 
rIL-2  61  34  0.0  0.0  61  56  6.4  5.5 
2  Medium  8  3  0.0  0.0  22  23  0.6  0.5 
rIL-2  19  8  0.0  0.0  52  56  3.2  10.8 
3  Medium  I0  2  0.0  0.0  22  25  0.4  0.9 
rIL-2  57  23  0.0  0.0  89  90  2.1  3.1 
* PBL from three donors were cultured for 1 and 4 d (37°C, 2 ×  106 cells/ml) in RPMI  1640, 10% 
FBS medium with or without 133 ng/mi rIL-2. 
* The cytotoxic activity of cultured PBL was assayed in a 3-h 51Cr-release  assay using K562 or RDMC 
target cells. 
e The number of Leu-4  + and B73.1 + cells incorporating [3H]TdR was detected  by simultaneous use 
of autoradiography and indirect rosetting techniques. 
! LU/10  ~  cells. 
Percent cells incorporating  [SHITdR. 
of these investigations, however, were hampered by either the use of incompletely 
purified IL-2 or by an inadequate identification of the effector cells as NK cells. 
Although  natural  IL-2  purified  to  apparent  homogeneity  was  used  in  some 
studies, in other studies contamination with small amounts of potent activators 
of NK cells such as IFN or phorbol esters, was difficult to exclude. The  use of 
homogeneous rIL-2 almost rules out the possibility of contaminant factors. Much 
more  serious  concern  is  raised  about  the  criteria  used  to  identify  NK  cells. 
Cytotoxicity against NK-sensitive target cells is not sufficient to identify NK cells, 
because other cell types, e.g., activated T  cells, may share this property (48, 49). 1162  NATURAL KILLER CELLS AND INTERLEUKIN 2 
In most other studies, the identification of NK cells has been based on separation 
of cells on Percoll discontinuous gradients and on their reactivity with antibody 
HNK-1 (11). The use of Percoli gradients (38) has greatly helped in identifying 
NK cells as large granular lymphocytes (LGL) and in obtaining NK cell-enriched 
preparations;  however,  it  is  now  clear that  purification  of light  density cells 
cannot be used for positive identification of NK cells. A clearcut example is given 
by the identification of the cells producing IFN-a as NK cells on the basis  of 
results of Percoll separation (50), whereas a more detailed analysis of the surface 
markers of those cells established that they belong to a cell type copurifying with 
NK cells on Percoll gradient, but devoid of cytotoxic activity and separable from 
NK cells by use of monoclonal antibodies (51). In addition to the contamination 
with IFN-oz-producing cells, the low-density Percoll fractions are also likely to 
contain a small number of activated T  cells or immature lymphoblasts that are 
able to respond to IL-2. The use of the HNK-1 antibody is also not discriminating 
because recent studies have clearly established that this antibody (a) reacts only 
with a variable proportion of cytotoxic NK cells (from 20 to 60%) (26, 28), (b) 
does not react with presumably immature NK cells in human cord blood (22, 
52), and (c) reacts with a significant proportion of cells with the surface phenotype 
of mature T  cells, either OKT8- or OKT4-positive (53 and unpublished data), 
suggesting that the antigen detected may be present at some stage of differentia- 
tion and/or activation of T  cells and of other hematopoietic and nonhemato- 
poietic cell types. The use of monoclonal antibodies to the low-affinity FcR of 
NK cells and neutrophils (such as B73.1  and VEP13) appears at present to be 
the most specific way to identify the NK cell subset within the peripheral blood 
mononuclear cells because  (a)  B73.1  (and  the other antibodies)  recognizes a 
lymphocyte subset that does not express any T  cell markers except the ER (on 
80-90%  of cells) and OKT8  antigen (at low density on  30-50%  of the cells), 
which have been shown to be present on an equivalent proportion of cytotoxic 
NK cells (22,  23,  25,  26,  54);  (b) virtually all  NK activity is contained in  the 
B73.1 + subset (22); (c) >80%  of the IFN-treated B73.1 + cells on average, and 
100% in some experiments, bind to K562 target cells (22); and (d) in single-cell 
cytotoxicity assays in  agarose,  60-70%  of the B73.1 ÷ cells that are bound to 
K562 cells lysed the target cell during a 3-h incubation (55). 
In  the present study,  we analyzed the ability of pure recombinant IL-2  to 
enhance the activity of human peripheral blood NK cells in a short-term (18 h) 
culture and compared the ability of rIL-2 to induce proliferation of NK cells in 
those short-term cultures with that observed in  longer term (4-6 d) cultures. 
The rIL-2 was a  very potent activator of NK cell activity, both against target 
cells susceptible to fresh NK cells or relatively resistant to their cytotoxic effect. 
At optimal concentrations, rIL-2 was as effective or more effective than IFN-a 
in enhancing NK activity, but no significant difference in the relative efficiency 
of IL-2-activated (18-h culture) vs. IFN-activated NK ceils against various target 
cells was observed. The kinetics of IL-2-mediated enhancement was rapid and 
similar to that observed with  IFN.  Enhancement of NK activity preceded any 
proliferation induced by IL-2  in  the resting NK cells. The lymphocyte subset 
responsible for the enhancement of cytotoxic activity was clearly identified as 
that containing spontaneous and IFN-inducible NK activity, using monoclonal TRINCHIERI  ET  AL.  1163 
antibodies  and  C  in  negative  selection  procedures  and  also  in  negative  and 
positive selection procedures using indirect rosetting. The facts that (a) identical 
results were obtained using PBL treated with antibody and C  either before or 
after IL-2 treatment,  and (b) 50% target cell lysis is observed at an effector-to- 
target cell ratio of 3:1 or less, after IL-2 treatment of B73.1 ÷ cells, argue against 
the possibility that  the observed enhancement  of cytotoxicity is due to a  small 
proportion  of immature  NK  cells induced  to differentiate  and/or  proliferate. 
The  possibility  that  these  results  could  depend  on  the  presence  of a  minor 
cytotoxic population with very high recycling ability seems unlikely, due to the 
limited recycling ability (56) and rapid exhaustion of both resting and activated 
NK cells (57).  The  observation  that  IL-2 treatment  induces  differentiation  of 
OKM1-  to  OKM1 +  NK  cells  (10)  was  not  supported  in  the  present  study. 
Although the OKM 1 antigen (C3bi receptor) was the only surface antigen of T 
or NK cells whose expression was significantly enhanced by rIL-2 treatment,  no 
difference in  the number  of OKM1 + cells before or after  IL-2  treatment  was 
observed in our study. It should be pointed out that the expression of the OKM 1 
antigen on NK cells is extremely heterogeneous, with some cells expressing it at 
very low density. If less sensitive conditions in the immunofluorescence technique 
and cytofluorometric analysis are used, and if a threshold for distinction between 
positive and  negative cells is set that  fails to detect low-intensity OKM1 ÷ cells, 
then an apparent increase in the number of OKM 1  + cells, actually reflecting the 
increase in OKM 1 antigen density induced by IL-2, could be easily misinterpreted 
as the  induction  of differentiation  of OKM1-  into  OKM1 ÷ cells.  Our  results, 
therefore,  show that,  in short-term  cultures,  rIL-2  induces an enhancement  of 
cytotoxic activity in a  cell subset with phenotypic characteristics of mature  NK 
cells,  although  no  information  is  yet  available  at  the  single  cell  level  about 
whether  IL-2  potentiates  the  activity of already  cytotoxic cells,  increases  the 
proportion of mature NK cells with cytotoxic ability, or, like IFN, does both. 
The concentration  of rIL-2 required to enhance NK cytotoxicity is ~10-fold 
that required for half-optimal proliferation of CTLL cells in a standardized assay. 
However, the cell concentration  in the proliferation  assay (5  ×  104 cells/ml) is 
100-fold lower than that of PBL (5 x  106/mi) used in the present experiments. 
The concentration of rIL-2 required for proliferation  has been shown to quan- 
titatively correlate with the density of the responder cells (2). In the PBL culture, 
we  are  unable  to  determine  the  relative  density  of rIL-2-responder  cells  vs. 
bystander cells. However, if one assumes that all or most of NK cells (on average, 
15%  of PBL) are potential  IL-2 responders,  the quantity of IL-2 required  for 
CTLL proliferation  (and for proliferation of human T  cells, data not shown) is 
very close or  identical  to  that  required  for  enhancement  of NK  cell  activity. 
Considering  that  the specific activity of rIL-2 is comparable to that of natural 
IL-2, it is possible to envision an enhancing effect of IL-2 on NK cell cytotoxicity 
in physiological conditions.  Human  lymphocytes stimulated  with mitogens pro 
duce 3-8 ng of IL-2 per milliliter per  10  6 cells. These concentrations of IL-2 are 
sufficient to enhance NK cell activity, even if not to optimal levels. It is conceiv- 
able that  higher  local concentrations  of IL-2  can  be reached  in  vivo and  that 
other factors such as IFN act synergistically with IL-2 to lower the threshold of 
NK cell responsiveness.  On  the basis of the  level of IL-2 able to enhance  NK 1164  NATURAL  KILLER  CELLS  AND  INTERLEUKIN  2 
activity in vitro, therefore, a physiological role for IL-2 in regulating the cytotoxic 
activity of mature NK cells seems a reasonable postulate. 
Treatment of human PBL with rIL-2 induces a dose-dependent production of 
IFN-~. Both human and murine T  (58) and NK cell clones (11) have been shown 
to produce IFN-~, in response to antigens or IL-2. Several authors reported that 
IL-2 acts synergistically with other stimuli to induce IFN-~, (59), and some studies 
have  demonstrated  that  IL-2  alone  can  induce  IFN-~¢ production  (13,  60). 
Production of IFN-~ in 3-d cultures of human PBL in the presence of IL-2 has 
been attributed to T  cells or Percoll-separated, low-density lymphocytes. IFN-~, 
has  been  shown  to  be  produced  by  NK-like  cells,  with  the  participation  of 
macrophages, in  short-term (24 h) cultures of mouse spleen cells (60).  In this 
paper, we show that the major or only producers of IFN-y in  18-h cultures in 
the presence of rIL-2  are  B73.1 +,  B36.1-  NK  cells.  In  a  series  of four cell 
separation experiments, unseparated PBL produced, on average, <20 U/ml of 
IFN-%  whereas B73.1 + cells  produced >400  U/ml.  This  discrepancy with  a 
report (13) showing production by T  cells is not clear, although, as discussed 
below, in the 3-d incubation period used in that study, proliferation of IFN-3,- 
producing T  cells might have occurred. Although in our hands, IFN-~, is not as 
potent as IFN-0e in activating NK cells, the possibility exists that the enhancement 
of NK activity induced by IL-2 is mediated by the IFN--¢ produced. Weigent et 
ai.  (8)  showed  that  antisera  to  IFN-~,  could  completely block  IL-2-induced 
enhancement of NK activity. In our experiments and in those of Weigent et al. 
(8),  production of IFN-~ preceded or paralleled the increase in NK activity, a 
result difficult to interpret, as the secreted IFN-3,  should act secondarily on NK 
cells to enhance their activity. IFN-~, was reported to enhance NK activity with 
a kinetics slower than that observed with IFN-oe (61). Moreover, three different 
monoclonal antibodies to IFN-~, at concentrations able to completely neutralize 
the antiviral activity produced in the supernatant fluid of the IL-2-containing 
PBL culture and to block the enhancement of NK activity induced by exogenous 
IFN-~, failed to prevent the enhancement of NK activity by rIL-2. These data 
suggest  that  IFN-~,  does  not  play  a  major  direct  role  in  the  IL-2-induced 
enhancement of NK activity. The discrepancy between our results and those 
reported by Weigent et al. (8) might rest in the more restricted specificity of the 
monoclonal antibodies in comparison with the polyclonal antisera. However, it 
is  also  possible  that  concentrations  of IFN-3¢ higher  than  those  that  can  be 
immediately inactivated by the antibodies are reached within the IFN-producing 
cells and NK cells in  the cell pellet.  Moreover, a  direct cell-to-cell transfer of 
IFN-~,-induced NK-enhancing activity, not inhibitable by anti-IFN  antibodies, 
could be responsible for the enhancement of NK cell activity, in a way analogous 
to that demonstrated for cell-to-cell transfer of antiviral activity (62). 
The enhancement of NK cell activity observed in our experiments precedes 
any proliferation induced by rIL-2, as shown in autoradiography by the absence 
of any NK or T  cells incorporating [3H]TdR at the end of the 18-h incubation. 
However, if the culture of B73.1 ÷ NK cells and B73.1- cells in the presence of 
irradiated monocytes is continued for 4-6 d, proliferation, as evaluated by [3H]- 
TdR  incorporation,  is  observed  in  both  cell  subsets.  These  results,  showing 
proliferation of both  NK and of B73.1-  cells, devoid of NK activity, contrast TRINCHIERI ET AL.  1165 
with a recent preliminary report by Shiiba et al. (11) that attributes the prolif- 
eration  induced  by  IL-2  in  fresh  PBL  entirely  to  NK  cells,  based  on  the 
copurification of proliferating cells in low-density Percoli gradient fractions and 
on the partial blocking of proliferation by treatment of the cells with antibody 
HNK-1  and C. To determine whether cells with both NK (B73.1 +) and T  cell 
phenotype  (Leu-4  ÷)  were  induced  to  proliferate  by  rlL-2,  we  analyzed  the 
phenotype of the cells incorporating [3H]TdR after a 4-d culture in the presence 
of rlL-2. We have previously  2 shown that antibodies B73.1 and Leu-4 recognize 
two separate nonoverlapping subsets of lymphocytes both in fresh (22)  and in 
proliferating PBL. rlL-2 induced a significant increase of [SH]TdR-incorporating 
cells after 4 d of  cultures. [SH]TdR-incorporating lymphocytes  could be identified 
both in B73.1 + and Leu-4  ÷ cell subsets. These results show that rlL-2 can directly 
induce a proportion of NK cells to proliferate, but can also induce cells expressing 
specific T cell markers. The results reported by Shiiba et al. (11) could be possibly 
due to the presence of cells other than NK in the light-density cell fraction, e.g., 
immature or  activated  T  cells,  or  to  the  absence  of accessory cells,  such  as 
monocytes, in  the unresponsive high-density cell fractions.  Grimm et al.  (16) 
have shown that the LAK cells, generated in 3-5-d cultures by pure IL-2 (17) or 
by rlL-2 (19), express the Leu-4 antigen, proliferate in culture, but are derived 
from Leu-4- immature T  precursors that are distinct from NK cells, but copurify 
with them on a  Percoll gradient.  A  portion of the Leu-4  ÷ cells incorporating 
[SH]TdR observed in our 4-d culture could possibly be LAK cells. 
Unlike activated proliferating T  or NK cells, resting PBL reveal only a  very 
limited number of high-affinity IL-2 receptors as demonstrated either by IL-2 
binding or by reactivity with antibody anti-Tac. The question emerges of which 
type of surface IL-2 receptor allows resting mature peripheral blood NK cells to 
respond rapidly and efficiently to IL-2 with enhanced cytotoxic activity and IFN 
production.  In  the  present  study,  anti-Tac  was  unable  to  reduce  the  IL-2- 
mediated enhancement of NK activity in short-term cultures. Even much higher 
dilutions of anti-Tac have been reported to block generation of LAK cells in 
longer  cultures  as  well  as  IL-2-dependent  human  T  cell  proliferation  (17). 
However,  a  role  for  the  IL-2  receptor  recognized  by  anti-Tac  in  NK  cell 
enhancement cannot be excluded. The binding affinity of IL-2 to its receptor 
(5, 6) is much higher than that of an antibody, and, especially when relatively 
high IL-2 concentrations and cell densities are used, as in our experiments, anti- 
Tac may fail to compete for IL-2 binding, even when the recognized receptor is 
responsible for the binding. We are currently analyzing the binding of rlL-2 to 
highly purified preparations of resting NK cells in an effort to define the number 
of receptors  on  NK  cells,  their  binding  affinity,  and  their  biochemical  and 
antigenic relationship with the Tac antigens. 
Summary 
The present study shows that  recombinant interleukin  2  (IL-2) purified to 
homogeneity induces a rapid and potent enhancement of spontaneous cytotox- 
icity of human peripheral blood lymphocytes. The cells mediating cytotoxicity 
after 18-h treatment with IL-2 have surface markers of natural killer (NK) cells 
and  are  generated  from  the  peripheral  blood  subset  containing spontaneous 1166  NATURAL  KILLER CELLS AND  INTERLEUKIN  2 
cytotoxic cells. A parallel production of gamma interferon (IFN-3,) is induced by 
recombinant IL-2 (rIL-2), and  NK cells appear to be the major producer cells, 
whereas T  cells are unable to produce IFN-y under these experimental condi- 
tions.  However, the kinetics of the enhancement of cytotoxicity are faster than 
those of IFN-~, production, and monoclonal anti-IFN-~, antibodies do not sup- 
press this effect, making it unlikely that the IFN-~, produced is responsible for 
the  enhancement.  The  enhancement  of  NK  cell  activity  induced  by  rIL-2 
precedes any proliferative response of the lymphocytes, which is instead observed 
in longer-term cultures of both NK and T  cells. 
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